| NCT ID | NCT07569666 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zagazig University |
| Condition | Atrophic Scar |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2025-06-15 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2025-06-15 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lay Summary (Simple Explanation) Atrophic scars are depressed scars that form when the skin does not heal properly, commonly seen after acne or injuries. These scars can affect appearance and confidence, and current treatments may not always give satisfactory results. This study aims to evaluate a new treatment using exosomes, which are tiny particles naturally released by cells that help in skin repair and regeneration. Researchers will compare the effect of injecting exosomes directly into scars versus injecting a simple saltwater solution (saline), which serves as a control. Participants will be randomly assigned to receive either exosome injections or saline injections. Neither the patient nor the evaluator may know which treatment is given, to ensure fair comparison. The goal is to determine whether exosomes can safely and effectively improve the appearance and texture of atrophic scars.
Eligibility Criteria
Inclusion Criteria: Age \>18 years * Either gender * Scars of any duration * Multiple scars at one side or both sides of the face. * Patients are willing to sign written informed consent statements before beginning treatment. Exclusion Criteria: * Pregnant females. * Patients with one scar. * Hypersensitivity to any of the used treatments. * Patient with infection at the site of the scar. * Patients with unrealistic expectations. * Patient refusing to sign on the consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07569666 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrophic Scar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07569666 currently recruiting?
Yes, NCT07569666 is actively recruiting participants. Contact the research team at monaelradi@medicine.zu.edu.eg for enrollment information.
Where is the NCT07569666 trial being conducted?
This trial is being conducted at Zagazig, Egypt.
Who is sponsoring the NCT07569666 clinical trial?
NCT07569666 is sponsored by Zagazig University. The trial plans to enroll 12 participants.